Orzel (UFT+ Leucovorin [Tegafur/uracil + folinic acid]) as First-Line Therapy for Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Feb 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Sep 2005 New trial record.